WESTFORD, Mass., June 2 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker are scheduled to present at the following investor conferences in New York City this month: -- Gabelli & Company Healthcare Symposium, Tuesday, June 9; the presentation is scheduled to begin at 9:00 a.m. ET. -- Needham & Co. 8th Annual Life Sciences Conference, Wednesday, June 10; the presentation is scheduled to begin at 1:00 p.m. ET. -- Jefferies 3rd Annual Healthcare Conference, Thursday, June 18; the presentation is scheduled to begin at 8:30 a.m. ET. Investors interested in listening to the live webcasts of these presentations should log on to the "Investor Relations" section of Cynosure's website, http://www.cynosure.com/, and click on the link labeled "Events." The presentations also will be archived on the company's website. About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com/. Contact Scott Solomon Vice President Sharon Merrill Associates, Inc. 617-542-5300 DATASOURCE: Cynosure, Inc. CONTACT: Scott Solomon, Vice President of Sharon Merrill Associates, Inc., +1-617-542-5300, , for Cynosure, Inc. Web Site: http://www.cynosure.com/

Copyright